Disability

Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence

With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping…

2 months ago

Remedy Robotics Debuts Pioneering Endovascular Surgical Robotic System and Completes World’s First Fully Remote Neurointerventional Procedures

Groundbreaking remotely operable robotic system to transform intervention for stroke and cardiovascular disease, while radically expanding access to care for…

2 months ago

CENTEGIX® and Sudden Cardiac Arrest Foundation Partner to Elevate Lifesaving Preparedness During Sudden Cardiac Arrest Awareness Month

ATLANTA, Oct. 6, 2025 /PRNewswire/ -- In recognition of Sudden Cardiac Arrest Awareness Month, CENTEGIX is partnering with the Sudden…

2 months ago

bobo, the AI-Driven Parenting Intelligence Platform, Launches in the United States

Revolutionary technology empowers parents with advanced insights about their children's development, transforming reactive pediatric care into proactive health monitoring WINNIPEG,…

2 months ago

Clario and the University of Oxford’s NeuroMetrology Lab Advance Parkinson’s Disease Research with the Opal® Wearable Sensor System

Clario partners with the University of Oxford's NeuroMetrology Lab to transform Parkinson's disease research with the Opal® wearable sensor system. Partnership…

2 months ago

LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia, Including Positive Effects on Cognition and Negative Symptoms

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced…

2 months ago

Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy

Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic…

2 months ago

Symetra Completes Acquisition of Dearborn Group’s Life & Disability Business, Enters Distribution Agreement

BELLEVUE, Wash.--(BUSINESS WIRE)--Symetra Life Insurance Company announced that its acquisition through reinsurance of Dearborn Group’s life and disability (LAD) business…

2 months ago

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company…

2 months ago

Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine

First and Only REN-Based Migraine Treatment Approved in China BEIJING and NETANYA, Israel, Sept. 29, 2025 /PRNewswire/ -- Pier 88 Health, a…

2 months ago